Connect Biopharma Holdings Ltd
Ownership
Ownership Structure
Who owns Connect Biopharma Holdings Ltd (CNTB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 27.5% of the shares are freely tradable; institutional investors hold 56.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Quadrature Capital Limited | 0.07 | 42,303 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Small-Cap Index I | 0.00 | 2,282 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Xanthopoulos Kleanthis Gabriel | Director | 91,554 | 60,911 $ | Sep 30, 2026 | direct |
| Liu Jean I | Director | 20,763 | 13,814 $ | Sep 30, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Xanthopoulos Kleanthis Gabriel | Director | Other | 5,000 | 0.00 | – |
| Sep 30, 2026 | Liu Jean I | Director | Other | 8,984 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.